WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 31'6291 Child (under 5 years) mortality rate: 162

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 372  366  360  354  348  298  256  211 
Births
Surviving infants
Pop. less than 5 years 29  28  27  27  27  28  28  25 
Pop. less than 15 years 81  81  81  83  84  87  83  78 
Female 15-49 years 104  103  102  100  98  84  70  55 

Number of reported case

(Click for retrospective incidence data for Bahamas (the))
Diphtheria
Japanese encephalitis
Measles 72  484 
Mumps
Pertussis 15 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bahamas (the))
Vaccine year result method % card seen                                                
BCG         
DTP1          99  99*  99*  100  100  99* 
DTP3          98  98  99  96  93  99  87  36 
HepB_BD         
HepB3          96  95  98  95  90 
Hib3          98  98  98  96  94  90 
JapEnc         
MCV          91  90  94  98  90  93  99 
MCV2          73  79  47  76 
PCV1          77  13 
PCV3          37 
Pol3          99  97  97  97  93  91  82  35 
Rota1         
Rota_last         
Rubella1          91  90  94  98  90 
TT2plus          97  95  96  96 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bahamas (the))
DTP1 99  99  99  99  99  99  95  61 
DTP3 98  98  99  96  93  99  86  36 
HepB3 96  95  98  95  90 
Hib3 98  98  98  96  94  90 
MCV 91  90  94  98  90  93  86 
PAB 92  92  90  90  90  85  71 
PCV3 37 
Pol3 99  97  97  97  93  91  82  35 
Rota_last

Number of districts in the country 91  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 99
From 80 to 89% 1
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 2, 4, 6 months; No
DTaPHibIPV 2, 4, 6 months; No
DTwPHib 15 months; Yes
DTwPHibHep 2, 4, 6 months;
HepB 2, 4, 6 months; Yes and 1st contact, +1, +6 monmths for adults
IPV 2, 4, 6 months; 4-5 years; Yes In the public sector given only to risk groups
Influenza Yes Infants, adults and risk groups
MMR 1, 4-5 years; Yes
OPV 2, 4, 6 months; 4-5 years; Yes
Pneumo_conj 2, 4, 6, 15 months; Yes
Rotavirus 2, 4 months; No
Td 10-12 years; Yes every 10 years
Tdap 10-12 years Yes every 10 years
Varicella 1, 4-5 years; Yes
YF travelers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2020  2010-2015  2010-2012  2'012  2'012  2007-2015  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number   10  10  85  10 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 91  91  31  31  31  85  92 
Nº districts with DTP3 coverage >=80% number 91  23         
% of districts with DTP3 coverage >=80% From 0 to 100% 100  25         
Nº districts with measles (MCV1) coverage >=95% number 35  23         
% of districts with MCV1 coverage >=95% From 0 to 100% 38  25         

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.